Good MorningEquities slipped on Wednesday following a mad dash for the exits on Tuesday. The S&P 500 fell about 0.25% at the low of the day on fears of slowing economic activity and an earnings recession that could begin as soon as the current quarter. While several reports have come in better than expected the strength is isolated and the signs of economic headwinds are growing. If this trend continues it could lead to a significant revision to the 2nd half outlook that drives the market even lower and that is not the only risk. The PCE price index is expected to come in hot and increase the odds not only of aggressive FOMC action but a major recession as well.
In regards to stocks, the defensive Consumer Staples stock General Mills was among the market's leaders on Wednesday. The stock represents not only a value to investors but a high yield that is backed upped by results. General Mills' 2nd quarter earnings were better than expected and came with an increase in guidance that we think will be echoed across the sector. Featured: Wall Street’s quietly buying these 3 AI infrastructure plays (Ad) 
|
Consumer Staples | |
RH Confirms Retail Trends Are Worsening
RH (NYSE: RH) was one of the biggest winners from the pandemic boom and now it is one of the biggest losers of the pandemic bust. More importantly, because of when it reports in the reporting cycle, it has provided insight into the upcoming quarter and wha... Read the Full Story |
|
From Our Partners | | BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid.
The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned. | | Get the name, the ticker, and exactly how to buy it |
|
Basic Materials | |
Rio Tinto Group (NYSE: RIO) is in the business of mining and processing commodities across the world, but perhaps the most important material it delivers is iron ore. RIO has the largest portfolio of iron ore assets with 16 mines. The demand for this raw material is set to grow worldwide at a CAGR... Read the Full Story |
|
Markets | | Software provider to property and casualty insurers Guidewire Software (NYSE: GWRE) stock has plunged (-31%) in this year but is staging a comeback with the launch of its first Guidewire Cloud offering known as Elysian. Guidewire provides mission-critical essential software systems to the $2.5 trill... Read the Full Story |
|
From Our Partners | | See the Signals Most Traders Miss
We monitor subtle shifts in order flow, volume patterns, and early trend behavior.
Stock News Trends highlights moves long before they hit mainstream screens. | | Join Free — Start Tracking Early Market Data |
|
Energy | |
For many investors, that Fourth of July weekend can’t come soon enough.
In the coming days we’ll be reminded often that U.S. stocks turned in their worst first half performance since 1970.
To some, this will serve as notice to stay on the sidelines until market conditions improve. Ot... Read the Full Story |
|
Markets | |
Acuity Brands Wobbles After Strong Q3 Results
Acuity Brands (NASDAQ: AYI) has been in a downtrend for the last two quarters for no other reason than fear of slowing growth, tightening margins, and earnings weakness but those fears were overblown. The move downward was driven in large part by ins... Read the Full Story |
|
From Our Partners | | With OpenAI and Anthropic moving closer to the IPO spotlight, AI excitement could spill into several public-market sectors this summer - and most investors may chase the obvious names too late.
A free report identifies 7 stocks positioned around themes that could matter most this summer: AI infrastructure, energy demand, travel, entertainment, home improvement, and more. Built for a market where leadership may rotate quickly. | | Download 7 Best Stocks to Own in Summer 2026 for free |
|
Technology | | Paychex (NASDAQ: PAYX) is an American provider of human resources, payroll, and outsourcing services for small and medium-sized businesses. The company is based out of Rochester, New York, and has payroll clients across North America and Europe.
Highlights:
-Services revenue increased by 11% for t... Read the Full Story |
|
Medical | |
Pfizer Inc. (NYSE: PFE) has a bright future ahead of it. Detractors of the company point to the fact that COVID-19 has reached its peak, and therefore the company will experience reduced demand for one of its best-selling vaccines. However, it is also becoming apparent to me that the virus will re... Read the Full Story |
|
Retail/Wholesale | |
Walgreens Boots Alliance Falls On Mixed Results
Walgreens Boots Alliance (NASDAQ: WBA) is one of our top picks for long-term oriented high-yield investors because of the turnaround story. The company has been working to realign itself for growth over the past few years and those efforts are work... Read the Full Story |
|
Markets | |
SGH Was A Smart Buy, Now Its A Compelling Value
SGH (NASDAQ: SGH) has been a smart buy for the last two years or so and now the value is as compelling as it has ever been. The company just released Q3 earnings to beat expectations, announced a major acquisition that should be immediately accretiv... Read the Full Story |
|
Technology | |
The glass-half-empty view will show that shares of Snowflake (NYSE: SNOW) were trading down as much as 70% from last year’s highs only two weeks ago. They’d been in freefall since May’s earnings report and seemed intent on setting new all-time lows for the rest of the summer. But... Read the Full Story |
|
Friday's Early Bird Stock Of The Day Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California. | | View Today's Stock Pick |
|
